Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

Show Description +

Charles Wykoff, MD, PhD, reviews the results of the 6-month prospective phase 1/2 HULK study evaluating the use of preservative-free suprachoroidal triamcinolone acetonide in patients with DME. Dr. Wykoff notes the efficacy of intravitreal anti-VEGF therapy and corticosteroids in patients with DME and explains how the open-label, multicenter study expanded on this with suprachoroidal delivery of corticosteroids to 20 previously treated or treatment-naïve patients. Anatomic efficacy was demonstrated across all eyes, and visual acuity gains were also seen, largely driven by the treatment-naïve population.

Posted: 11/17/2017

Keywords:

HULK

•

suprachoroidal drug delivery

•

Retina Subspecialty Day

Up Next

DME Outcomes Following TREX

David Brown, MD

Gene Therapy for Wet AMD

Szilárd Kiss, MD

Head-to-Head Trials

Pravin Dugel, MD

Who, What, Where, and When?

Arsham Sheybani, MD, Ike Ahmed, MD

An Update on GATT

Davinder Grover, MD

Managing Uveitic Glaucoma

Allen Beck, MD

Glaucoma: A Two-Pressure Disease?

John Berdahl, MD

Who Should Perform MIGS?

Michael Patterson, DO

Iris Prostheses: From Bench to Bedside

Michael Snyder, MD

Hot Topic: Is Astigmatism Correction a Must?

George Waring IV, MD, Neel Desai, MD, Zaina Al-Mohtaseb, MD

Updates on Sjögren Syndrome

Stephen Pflugfelder, MD

Treatment Options in Patients With Chronic DME

Nathan Radcliffe, MD

Who Should Perform MIGS?

Osamah Saeedi, MD

The Application of Meibography Imaging to Detect DED

Jennifer Loh, MD

Hot Topic: Technologies in 2018

Robert Weinstock, MD, Roger Zaldivar, MD

The Future of Cross-linking

William Trattler, MD

A Diagram for Posterior Capsule Rupture

Ashvin Agarwal, MD

Should We Still Be Doing DSAEK?

Winston Chamberlain, MD, PhD

Combating Patient Dissatisfaction After Multifocal IOL Implantation

John Berdahl, MD

Hot Topic: Pharmaceutical Compounding

Keith Walter, MD, Nathan Radcliffe, MD, Tal Raviv, MD

A Pragmatic Approach to Surgical Evaluation

Roger Zaldivar, MD, MS, MBA

Corneal Transplantation in the Era of Femtosecond Laser

Marjan Farid, MD

Pitfalls for Corneal Inlays in Presbyopic Patients

George Waring IV, MD

Hot Topic: Successful Collaborations

Constance Okeke, MD, Greg Parkhurst, MD, John Berdahl, MD

Next-Gen Sequencing in Uveal Melanoma

J. William Harbour, MD

Back to All Videos

Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

Posted: 11/17/2017

Keywords:

HULK

•

suprachoroidal drug delivery

•

Retina Subspecialty Day

Please log in to leave a comment.

Comments

Deepak Bhojwani

7 years ago

EXCELLENT TALK DR CHARLES WYKOFF..I HAVE A SMALL REQUEST..CAN YOU DESCRIBE THE TECHNIQUE FOR GIVING SUPRACHOROIDAL INJECTIONS...I MEAN IS IT SAME AS INTRAVITREAL INJECTIONS JUST THE PENETRATING NEEDLE IS DIFFERENT??

Meeting Coverage:

American Academy of Ophthalmology

Suprachoroidal Steroids for DME

Up Next

Suprachoroidal Steroids for DME

Comments

More From AAO: 2017 Coverage